Abstract
small organic molecules, able to induce, in vitro, osteogenesis, cardiomyogenesis, neurogenesis and dedifferentiation of stem cells, emerged form a library of heterocyclic compounds.
Keywords: gene therapy, regenerative therapy, embryonic stem cells, neurological diseases, pharmacogenomics, heterocyclic purine
Letters in Organic Chemistry
Title: Stem Cells Differentiation: Organic Chemistry is Back
Volume: 2 Issue: 2
Author(s): G. Zanoni and A. Vadala
Affiliation:
Keywords: gene therapy, regenerative therapy, embryonic stem cells, neurological diseases, pharmacogenomics, heterocyclic purine
Abstract: small organic molecules, able to induce, in vitro, osteogenesis, cardiomyogenesis, neurogenesis and dedifferentiation of stem cells, emerged form a library of heterocyclic compounds.
Export Options
About this article
Cite this article as:
Zanoni G. and Vadala A., Stem Cells Differentiation: Organic Chemistry is Back, Letters in Organic Chemistry 2005; 2 (2) . https://dx.doi.org/10.2174/1570178053203026
DOI https://dx.doi.org/10.2174/1570178053203026 |
Print ISSN 1570-1786 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6255 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Orthostatic Hypotension: Evaluation and Treatment
Cardiovascular & Hematological Disorders-Drug Targets Tyrosine Kinase Inhibitor-Induced Hypertension: Role of Hypertension as a Biomarker in Cancer Treatment
Current Vascular Pharmacology Telmisartan Blocks Advanced Glycation End Product (AGE)-Induced Plasminogen Activator Inhibitor-1 (PAI-1) Gene Expression in Endothelial Cells via Activation of Peroxisome Proliferator-Activated Receptor-γ (PPAR-γ )
Letters in Drug Design & Discovery Thiazolidinediones and Type 2 Diabetes: From Cellular Targets to Cardiovascular Benefit
Current Drug Targets Prevention of Bioprosthetic Heart Valve Calcification: Strategies and Outcomes
Current Medicinal Chemistry Ignored Avenues in Alpha-Synuclein Associated Proteopathy
CNS & Neurological Disorders - Drug Targets Hormone Replacement Therapy and Stroke
Current Vascular Pharmacology Importance of Receptor-targeted Systems in the Battle Against Atherosclerosis
Current Pharmaceutical Design Determination of Selenium in Eggs of Different Birds Using Sample Digestion in a Reflux System and Hydride Generation Atomic Fluorescence Spectrometry
Current Analytical Chemistry Relationships between Serotoninergic System and Skin Fibrotic
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry Pharmacotherapy in Systemic Lupus Erythematosus
Current Rheumatology Reviews Combining “Omics” Strategies to Analyze the Biotechnological Potential of Complex Microbial Environments
Current Protein & Peptide Science Immunomodulatory Activity of Mesenchymal Stem Cells
Current Stem Cell Research & Therapy Diabetes Beyond Insulin: Review of New Drugs for Treatment of Diabetes Mellitus
Current Drug Discovery Technologies Mitral Balloon Valvuloplasty: State-of-the-Art Paper
Current Cardiology Reviews Cardiovascular and Renal Complications of Type 2 Diabetes in Obesity:Role of Sympathetic Nerve Activity and Insulin Resistance
Current Diabetes Reviews Cholesterol Absorption Blockade with Ezetimibe
Current Drug Targets - Cardiovascular & Hematological Disorders Effect of Non-antihypertensive Drugs on Endothelial Function in Hypertensive Subjects Evaluated by Flow-mediated Vasodilation
Current Vascular Pharmacology Testosterone, Estradiol, and Sex Hormone-Binding Globulin in Alzheimer’s Disease: A Meta-Analysis
Current Alzheimer Research Beta-Blockers in Children with Congenital Heart Disease Before a Corrective Procedure
Reviews on Recent Clinical Trials